36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Medicine and Dentistry

• Venous Thromboembolism 100%
• Deep Vein Thrombosis 50%
• Pulmonary Embolism 40%
• Antithrombotic 40%
• Anticoagulation 20%
• All Cause Mortality 20%
• Patient Population 10%
• Malignant Neoplasm 10%
• Observational Study 10%
• Anticoagulant Therapy 10%
• Major Bleeding 10%
• Ciclonicate 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Venous Thromboembolism 100%
• Deep Vein Thrombosis 50%
• Anticoagulant Agent 40%
• Lung Embolism 40%
• All Cause Mortality 20%
• Observational Study 10%
• Anticoagulation Therapy 10%
• Malignant Neoplasm 10%
• Bleeding 10%
• Ciclonicate 10%